摘要
心房颤动是临床常见的心律失常,血栓栓塞为其严重并发症。本文主要就房颤并发血栓栓塞的发病机制、危险分层、治疗方法及进展,以及循证医学的证据做详细阐述。
出处
《世界临床药物》
CAS
2007年第3期147-151,共5页
World Clinical Drug
参考文献27
-
1KannelWB;Wolf PA;Benjamin EJ.Prevalence,incidence,prognosis,and predisposing conditions for atrial fibrillation:population-based estimates[J],1998(8A).
-
2黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动：目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量：270
-
3Wolf PA;Abbott RD;Kannel WB.Atrial fibrillation as an independent risk factor for stroke:the Framingham Study,1991(08).
-
4Kannel WB;Abbott RD;Savage DD.Epidemiologic features of chronic atrial fibrillation:the Framingham study[J],1982(17).
-
5Shorr RI;Ray WA;Daugherty JR.Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease,1993(14).
-
6Koefoed BG;Gullov AL;Petersen P.Prevention of thromboembolic events in atrial fibrillation[J],1997(01).
-
7Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin:Stroke Prevention in Atrial Fibrillation Ⅲ Study The SPAF Ⅲ Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators[J],1998(16).
-
8Kamath S;Blann AD;Chin BS.A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation[J],2002(03).
-
9Gallagher MM;Hennessy BJ;Edvardsson N.Embolic complications of direct current cardioversion of atrial arrhythmias:association with low intensity of anticoagulation at the time of cardioversion[J],2002(05).
-
10Miller VT;Rothrock JF;Pearce LA;Stroke Prevention in Atrial Fibrillation Investigators.Ischemic stroke in patients with atrial fibrillation:effect of aspirin according to stroke mechanism,1993(01).
二级参考文献28
-
1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1408
-
2刘少稳,杨延宗,高连君,李世军,尹晓盟,林治湖.心房颤动导管射频消融静脉电隔离前后的抗凝治疗[J].中国心脏起搏与心电生理杂志,2004,18(6):432-434. 被引量：11
-
3HUANG Cong-xin.Reinforce the study of treatment of atrial fibrillation by catheter ablation[J].Chinese Medical Journal,2005(14):1147-1149. 被引量：8
-
4WU Gang,HUANG Cong-xin,TANG Yah-hong,JIANG Hong,WAN Jun,CHEN Hui,XIE Qiang,HUANG Zheng-rong.Changes of I_(K,ATP)current density and allosteric modulation during chronic atrial fibrillation[J].Chinese Medical Journal,2005(14):1161-1166. 被引量：16
-
5LIU Jie,HUANG Cong-xin,BAO Ming-wei,WANG Teng.Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro[J].Chinese Medical Journal,2005(14):1210-1213. 被引量：13
-
6刘少稳,杨延宗.射频导管消融肺静脉电隔离过程中残存静脉电位的鉴别诊断[J].中华心律失常学杂志,2005,9(3):197-203. 被引量：2
-
7胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量：163
-
8Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the
-
9Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 2001,119(1 Suppl):8S-21S.
-
10Levine MN, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant treatment. Chest, 2001,119(1 Suppl):108S-121S.
共引文献430
-
1张芳,刘海涛,王元芳.品管圈在提高房颤患者规范服用华法林依从性中的应用[J].临床合理用药杂志,2020,13(4):7-9. 被引量：3
-
2张晓平.华法林抗栓治疗心房颤动患者血管内皮功能的变化[J].陕西医学杂志,2008,37(12):1670-1671. 被引量：3
-
3马希,孙飞,李莉娟,陶四明.心房纤颤56例口服华法林的护理[J].中国误诊学杂志,2009,9(5):1174-1175.
-
4马长生.心房颤动导管消融治疗评价[J].岭南心血管病杂志,2009,15(4):251-254. 被引量：1
-
5吴书林,薛玉梅.心房颤动患者血栓栓塞危险分层与抗凝治疗策略[J].岭南心血管病杂志,2009,15(4):264-267. 被引量：2
-
6胡雪松,裴晓阳,徐亚伟,于学靖,张新霞,颜雯,闵敏.三维标测系统指导心房颤动导管消融的临床研究[J].岭南心血管病杂志,2009,15(4):291-294.
-
7郭倩倩,周立春.微栓子监测在非卒中疾病中的诊疗价值[J].中华临床医师杂志（电子版）,2012,6(16):4830-4832.
-
8中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中国医学前沿杂志（电子版）,2011,3(3):84-93. 被引量：85
-
9黄从新.心房颤动研究的现状及前景[J].中国继续医学教育,2010,2(5):9-17. 被引量：6
-
10杨铁勇,李霞.心房纤颤抗栓治疗进展[J].兵团医学,2008(4):57-59.
同被引文献15
-
1史伟浩,余波,王铁平.急性下肢缺血的外科治疗(附35例病例分析)[J].中国现代医学杂志,2005,15(4):555-557. 被引量：11
-
2刘松年,荆凌华,李兰英.华法林预防老年非瓣膜病慢性心房颤动患者缺血性脑卒中的临床研究[J].国外医学（内科学分册）,2006,33(5):229-230. 被引量：13
-
3刘光平,刘敏,卢辉,祁建.华法林预防非瓣膜性房颤血栓栓塞症147例临床观察[J].南通大学学报（医学版）,2006,26(4):277-277. 被引量：2
-
4张靖,陈鹏,赵炎波.预防非瓣膜性心房颤动患者缺血性脑卒中的抗栓疗法比较[J].临床内科杂志,2007,24(1):69-69. 被引量：2
-
5张刚,曹雪滨,王士雯,崔英凯,毛继康,黄雄,杨梅.非瓣膜病性老年房颤患者华法林抗凝疗效及安全性研究[J].第三军医大学学报,2007,29(19):1918-1919. 被引量：11
-
6王振义,李家增,阮长,等.血栓与止血的理论与基础.第2版.上海:上海科学与技术出版社,2005.473-497.
-
7Schafer AI. Low-molecular weight heparin for venous thromboembolism. Hosp Pract, 1997, 31: 99.
-
8Earnshaw JJ, Whitman B, Foy C, et al. National audit of thromolysis for acute leg ischema: clinical factors associated with early outcome. J Vasc Surg, 2004, 39 (5): 1018-1025.
-
9Kottkamp H. Hindricks G Breithardt G. Role of anticoagulant therapy in atrial fibrillation. J Cardiovasc Electrophysiol, 1998, 9 (8 Suppl):S86-S96.
-
10Singer DE, Hylek EM. Optimal oral anticoagulation for patients with nonrtheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med, 1995, 333 (22): 1504-1508.
-
1黄定九.提高对心房颤动的认识和治疗水平——从基础到临床[J].中华心律失常学杂志,1998,2(4):245-246. 被引量：2
-
2黄定九.心房颤动的药物治疗[J].中华心律失常学杂志,1998,2(4):303-307. 被引量：3
-
3石进,李雅君,张维君.心房颤动患者抗栓治疗后消化道出血的分析[J].中华消化杂志,2007,27(3):197-198.
-
4苏昕.肾病综合征并发血栓栓塞的临床分析[J].中华今日医学杂志,2004,4(6):22-23.
-
5田玲玲,黄留业.炎症性肠病与血栓栓塞性疾病[J].世界华人消化杂志,2017,25(7):589-595. 被引量：2
-
6郭英祥,胡锡衷.防治心房颤动并发血栓栓塞的研究进展[J].福建医药杂志,1999,21(1):97-99.
-
7孙艺红.心房颤动谨防脑卒中与血栓栓塞[J].家庭医学（上半月）,2003,18(4):21-21.
-
8马春芬,党润芳,韩建伦.心房颤动并发血栓栓塞62例治疗分析[J].陕西医学杂志,2005,34(7):859-860.
-
9王锡三,汪惟实.心房颤动并发血栓栓塞危险因素的分析[J].心脏起搏与心电生理杂志,1995,9(4):203-204. 被引量：3
-
10秦孺子,李军,曾秋棠,曹林生.射频消融术并发血栓栓塞机制及防治对策[J].心血管病学进展,2002,23(2):88-91. 被引量：2
